Compare DEI & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DEI | UFPT |
|---|---|---|
| Founded | 1971 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2006 | 1996 |
| Metric | DEI | UFPT |
|---|---|---|
| Price | $9.50 | $191.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $12.94 | ★ $289.00 |
| AVG Volume (30 Days) | ★ 2.1M | 157.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 8.07% | N/A |
| EPS Growth | N/A | ★ 15.44 |
| EPS | 0.09 | ★ 8.75 |
| Revenue | ★ $1,003,982,000.00 | $602,797,000.00 |
| Revenue This Year | $2.29 | $8.12 |
| Revenue Next Year | $2.04 | $5.72 |
| P/E Ratio | $104.56 | ★ $21.88 |
| Revenue Growth | 1.77 | ★ 19.50 |
| 52 Week Low | $9.04 | $182.87 |
| 52 Week High | $16.94 | $274.93 |
| Indicator | DEI | UFPT |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 36.97 |
| Support Level | $9.41 | $185.32 |
| Resistance Level | $10.18 | $206.13 |
| Average True Range (ATR) | 0.30 | 7.74 |
| MACD | 0.03 | 1.57 |
| Stochastic Oscillator | 57.69 | 35.82 |
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.